Medicine and Dentistry
Prostate Cancer
100%
Partial Nephrectomy
49%
Neoplasm
41%
Kidney Tumour
35%
Biopsy Technique
34%
Prostatectomy
34%
Bladder
28%
Prostate Specific Antigen
26%
Diseases
25%
Cystectomy
22%
Clear Cell Renal Cell Carcinoma
21%
Malignant Neoplasm
19%
Lower Urinary Tract Symptom
18%
Chronic Pelvic Pain Syndrome
17%
Urinary System
17%
Surgeon
17%
Prostate Biopsy
15%
Recurrent Disease
13%
Dutasteride
13%
Transitional Cell Carcinoma
12%
Pelvis
12%
Interstitial Cystitis
11%
Bladder Cancer
11%
Bleeding
11%
Prostate Hypertrophy
11%
Cystalgia
11%
Magnetic Resonance Imaging
11%
Cancer
11%
Quality of Life
10%
Radical Nephrectomy
10%
Arm
10%
Nephrectomy
10%
Pediatrics
9%
Ovarian Cancer Screening
9%
Kidney Stone
9%
Systematic Review
9%
Odds Ratio
9%
Overall Survival
9%
Lung Cancer Screening
9%
Pelvis Pain Syndrome
9%
Gleason Score
8%
Cancer Risk
8%
Colorectal Cancer Screening
8%
Laparoscopic Surgery
8%
Ureteroscopy
8%
Ureter
8%
Incontinence
8%
Body Mass Index
8%
Kidney Function
7%
Overactive Bladder
7%
Cancer Screening
7%
Urologist
7%
Retroperitoneal Lymph Node Dissection
7%
Metastatic Carcinoma
7%
Kidney Cancer
7%
Non Muscle Invasive Bladder Cancer
7%
Urine Incontinence
7%
Enuresis
7%
Robot-Assisted Prostatectomy
7%
Health Care Cost
7%
Placebo
7%
Cryoablation
6%
Nephroureterectomy
6%
Stress Incontinence
6%
Ischemia
6%
Urinary Tract Infection
6%
Surgical Technique
6%
Radiation Therapy
6%
Percutaneous Nephrolithotomy
6%
Kidney Surgery
6%
Clinical Trial
6%
Logistic Regression Analysis
6%
Minimally Invasive Procedure
5%
Postoperative Complication
5%
Pyeloplasty
5%
Urology
5%
Cancer Mortality
5%
Robot-Assisted Surgery
5%
Obstruction
5%
Urinary Diversion
5%
Comorbidity
5%
Surgical Margin
5%
Meta-Analysis
5%
Keyphrases
Prostate Cancer
81%
Prostate Cancer Risk
23%
Lower Urinary Tract Symptoms
22%
Prostate Cancer Screening
22%
Laparoscopic Partial Nephrectomy
22%
Prostate-specific Antigen
20%
Radical Prostatectomy
20%
Renal Cell Carcinoma
19%
Tumor
19%
Dutasteride
19%
Bladder
18%
Prostate
18%
Robot-assisted Partial Nephrectomy
18%
Urologic Chronic Pelvic Pain Syndrome
18%
Renal Mass
15%
Bladder Pain Syndrome
15%
Benign Prostatic Hyperplasia
14%
Confidence Interval
14%
Radical Cystectomy
14%
Interstitial Cystitis
13%
Partial Nephrectomy
13%
Small Renal Mass
13%
Robotic Partial Nephrectomy
12%
Postoperative Outcomes
12%
Bladder Cancer
12%
Odds Ratio
11%
Prostate Biopsy
11%
Surgeons
11%
Overactive Bladder Symptom Score (OABSS)
11%
Ovarian Cancer Screening
11%
Active Surveillance
11%
Colorectal Cancer Screening
10%
Lung Cancer Screening
10%
Oncological Outcomes
10%
Chronic Pelvic Pain
10%
Operative Time
9%
Renal Tumor
9%
Kidney
9%
ACK1
9%
Multidisciplinary Approach
8%
Ureter
8%
Overall Survival
8%
Non-muscle Invasive Bladder Cancer (NMIBC)
8%
Upper Tract Urothelial Carcinoma
8%
Network Studies
8%
Total Prostate-specific Antigen
8%
Porcine Model
7%
Urinary Symptoms
7%
Robotics
7%
Robot-assisted Radical Cystectomy
7%
Tumor Size
7%
Multiparametric MRI (mpMRI)
7%
Placebo
7%
Radical Nephrectomy
7%
Urologists
7%
High-grade Prostate Cancer
6%
Multivariable
6%
Finasteride
6%
Ureteroscopy
6%
Urinary Incontinence
6%
Multi-institutional
6%
Urologic
6%
Genome-wide Association Study
6%
Robot-assisted Radical Prostatectomy
6%
Quality of Life
6%
United States
6%
Body Mass Index
6%
Prostate-specific Antigen Level
6%
Urinary Tract Infection
6%
5α-reductase Inhibitors
5%
Magnetic Resonance Imaging
5%
Digital Rectal Examination
5%
Meta-analysis
5%
Patient Selection
5%
Stress Urinary Incontinence
5%
Clinical Trials
5%
Prostate-specific Antigen Testing
5%
Percutaneous Nephrolithotomy
5%
Risk Factors
5%
Androgen Receptor
5%
Obesity
5%
Robotic Surgery
5%
Laparoscopic Radical Prostatectomy
5%
Functional Outcome
5%
Estimated Blood Loss
5%
Prostate Volume
5%
Prospective Randomized Trial
5%
Postoperative Complications
5%
Renal Function
5%
Length of Stay
5%
Hazard Ratio
5%
Randomized Trial
5%